ASP Isotopes Inc. develops isotope enrichment technologies and related critical-materials businesses for nuclear medicine, next-generation semiconductors, nuclear energy and helium markets. Company news commonly covers its Aerodynamic Separation Process and Quantum Enrichment platforms, enrichment facilities in Pretoria, South Africa, and target isotopes such as Silicon-28, Carbon-14 and Ytterbium-176.
Recurring updates also address PET Labs radiopharmaceutical operations, Quantum Leap Energy nuclear fuel-cycle initiatives, lithium laser enrichment research, Renergen and the Virginia Gas Project, material agreements, governance matters, capital-structure disclosures, and operating and financial results.
ASP Isotopes Inc. (ASPI) has completed its initial public offering (IPO) by closing the sale of 1,250,000 shares at a price of $4.00 each, generating approximately $5.0 million in gross proceeds. Shares began trading on the Nasdaq on November 10, 2022. The funds raised will support the construction of a Molybdenum enrichment facility in Pretoria, South Africa, along with other general corporate needs. The registration statement was declared effective on November 9, 2022.